Gunnar Sandberg. NCP Health, tel

Transcription

1 Gunnar Sandberg NCP Health, tel Gunnar.Sandberg@vinnova.se

2 IMI Contact person NCP Gunnar Sandberg Gunnar.Sandberg@VINNOVA.se IMI Memberstate representative Katarina Nordqvist Katarina.Nordqvist@VINNOVA.se Support for applicants SMINT/SME support preliminary Coordinator support preliminary IPR

3 Partnersökning för IMI NCP nätverk (speciell partnersökningformulär) Profil Registrera

4 FP Specific Programmes Cooperation Collaborative research Ideas Frontier Research People Human Potential Capacities Research Capacity + JRC JRC (non-nuclear) JRC JRC (nuclear) Euratom

5 FP7 budget - 54,582 (incl. Euroatom) (EUR billion, 2004 constant prices) Euratom 4,061 Capacities 4,217 JRC 1,751 Cooperation 32,365 People 4,728 Ideas 7,46

6 FP Cooperation budget I. Cooperation Budget ( million, 2004 constant prices) 1. Health Food, and agriculture and Biotechnology Information and Communication Technologies Nanotechnologies, materials and production Energy Environment Transport Socio-economic and Humanities Security & Space 2780 Total 32365* * Not including non-nuclear activities of the Joint Research Centre: million

7 FP Capacities budget I. Capacities Budget ( million, 2004 constant prices) Research Infrastructure 1850 Research for the benefit of SMEs 1336 Regions of Knowledge 126 Research Potential 370 Science in Society 280 International Co-operation 182 Total 4217

8 FP7 mjukstartade De sista 4 åren ( ) nästan 90 % kvar av budgeten.dvs ca 400 miljarder SEK Sverige succes rate ca 4% i FP6 ger 16 miljarder från FP7. VINNOVA är med i Pilotprojektet att påverka områden Hälsa, IKT, klimat, nano.

9 Next steps for the Health theme Call identifier: FP7-HEALTH-2009-single-stage Proposal submission and evaluation: Single-stage procedure Date of publication: 24 July Deadline: 20 November 2008 at 17:00:00 (Brussels local time). Indicative budget: EUR 476 million Call identifier: FP7-HEALTH-2009-two-stage Proposal submission and evaluation: Double-stage procedure Date of publication: 24 July Deadline: Indicative budget: EUR 115 million

10 Funding levels in the Health theme Warning: these will be an eligibility criteria! min. max.* Small- or medium-scale FRP 3m Large-scale (IP) > 6m 12m Projects targeted at (SMEs & SICA) 3m Networks of Excellence (NoE) > 6m 12m Coordination actions (CA) Support actions (SA) ERA-Nets (for cancer topic) 2m * except where otherwise stated in work programme.

11 Collaborative research in the Health theme 1: Biotechnology, generic tools and technologies 2: Translating research for human health 3. Optimising the delivery of healthcare to European citizens

12 Collaborative research in the Health theme 1: Biotechnology, generic tools and technologies High-throughput research enhancing data generation, standardisation, acquisition & analysis Detection, diagnosis and monitoring with emphasis on non-invasive or minimally invasive approaches Predicting suitability, safety and efficacy of therapies develop and validate parameters, tools, methods and standards (mainly through IMI) and alternatives to animal testing Innovative therapeutic approaches and interventions gene and cell therapy, regenerative medicine, immunotherapy and vaccines

13 Collaborative research in the Health theme 1: Biotechnology, generic tools and technologies High-throughput research enhancing data generation, standardisation, acquisition & analysis Detection, diagnosis and monitoring with emphasis on non-invasive or minimally invasive approaches Predicting suitability, safety and efficacy of therapies develop and validate parameters, tools, methods and standards (mainly through IMI) and alternatives to animal testing Innovative therapeutic approaches and interventions gene and cell therapy, regenerative medicine, immunotherapy and vaccines

14 Topics from first calls in Biotech, tools & technologies High-throughput research Topics third call (24 July 2008): HEALTH : Computational tools for genome annotation and genotype/phenotype data integration. FP7-HEALTH-2009-two-stage. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposals are expected to be funded. HEALTH : High throughput tools and technologies to analyse samples in large-scale human biobanks. FP7-HEALTH-2009-two-stage.. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposals are expected to be funded. HEALTH : Tools, technologies and resources for the characterisation of protein functions. FP7-HEALTH-2009-two-stage. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposals are expected to be funded.

15 Collaborative research in the Health theme 1: Biotechnology, generic tools and technologies High-throughput research enhancing data generation, standardisation, acquisition & analysis Detection, diagnosis and monitoring with emphasis on non-invasive or minimally invasive approaches Predicting suitability, safety and efficacy of therapies develop and validate parameters, tools, methods and standards (mainly through IMI) and alternatives to animal testing Innovative therapeutic approaches and interventions gene and cell therapy, regenerative medicine, immunotherapy and vaccines

16 Topics from first calls in Biotech, tools & technologies Detection, diagnosis and monitoring Topics third call (24 July 2008): -HEALTH : Development of tools for sensitive and specific in vitro detection of proteins and their interactions for diagnostic, prognostics and monitoring purposes. FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Design of methods suited to identify epigenetic factors and their use in the genetic diagnosis of relevant disorders. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Novel MR-compatible PET detectors for simultaneous PET/MRI imaging. FP7-HEALTH-2009-single-stage.. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Novel imaging systems for in vivo monitoring and quality control during tumour ion beam therapy. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). No more than one proposal will be funded. -HEALTH : Activatable or smart in vivo imaging agents reporting on physico-chemical or molecular changes relevant to the diagnosis and/or monitoring of diseases (in coordination with NMP theme). FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). Topic complementary to NMP Theme. -HEALTH : Evaluation of the potential health impact of Diagnostic Imaging agents doses. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination and Support Action (Supporting Action).

17 Collaborative research in the Health theme 1: Biotechnology, generic tools and technologies High-throughput research enhancing data generation, standardisation, acquisition & analysis Detection, diagnosis and monitoring with emphasis on non-invasive or minimally invasive approaches Predicting suitability, safety and efficacy of therapies develop and validate parameters, tools, methods and standards (mainly through IMI) and alternatives to animal testing Innovative therapeutic approaches and interventions gene and cell therapy, regenerative medicine, immunotherapy and vaccines

18 Collaborative research in the Health theme 1: Biotechnology, generic tools and technologies High-throughput research enhancing data generation, standardisation, acquisition & analysis Detection, diagnosis and monitoring with emphasis on non-invasive or minimally invasive approaches Predicting suitability, safety and efficacy of therapies develop and validate parameters, tools, methods and standards (mainly through IMI) and alternatives to animal testing Innovative therapeutic approaches and interventions gene and cell therapy, regenerative medicine, immunotherapy and vaccines

19 Topics from first calls in Biotech, tools & technologies Predicting suitability, safety and efficacy of therapies -HEALTH : New initiatives towards the implementation of the Replace, Reduce and Refine strategy. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination and Support Action (Coordinating Action).

20 Collaborative research in the Health theme 1: Biotechnology, generic tools and technologies High-throughput research enhancing data generation, standardisation, acquisition & analysis Detection, diagnosis and monitoring with emphasis on non-invasive or minimally invasive approaches Predicting suitability, safety and efficacy of therapies develop and validate parameters, tools, methods and standards (mainly through IMI) and alternatives to animal testing Innovative therapeutic approaches and interventions gene and cell therapy, regenerative medicine, immunotherapy and vaccines

21 Topics from first calls in Biotech, tools & technologies Innovative therapeutic approaches and interventions Topics third call (24 July 2008): Regenerative medicine HEALTH : Cell therapy for tissue and organs. FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposals are expected to be funded. HEALTH : Regeneration of tissue using bio-compatible materials and cells. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposals are expected to be funded. HEALTH : Activation of endogeneous cells as an approach to regenerative medicine. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposal is expected to be funded.

22 Collaborative research on the Health theme 2: Translating research for human health Integrating biological data and processes: large-scale data gathering, systems biology Research on the brain and related diseases, human development and ageing Translational research in major infectious diseases: to confront major threats to public health antimicrobial drug resistance, HIV/AIDS, malaria and TB, emerging epidemics, neglected infectious diseases Translational research in other major diseases: cancer, cardiovascular disease, diabetes and obesity, rare diseases, and other chronic diseases

23 Collaborative research on the Health theme 2: Translating research for human health Integrating biological data and processes: large-scale data gathering, systems biology Research on the brain and related diseases, human development and ageing Translational research in major infectious diseases: to confront major threats to public health antimicrobial drug resistance, HIV/AIDS, malaria and TB, emerging epidemics, neglected infectious diseases Translational research in other major diseases: cancer, cardiovascular disease, diabetes and obesity, rare diseases, and other chronic diseases

24 Topics from first calls in Translating research for health Integrating biological data and processes: large-scale data gathering Topics third call (24 July 2008): HEALTH : Large-scale functional genomics effort in multi cellular organisms to elucidate the function of human genes products. FP7-HEALTH-2009-two-stage. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposal is expected to be funded. HEALTH : Large-scale functional genomics efforts to identify molecular determinants of cancer. FP7-HEALTH-2009-two-stage. Funding scheme: Collaborative Project (Large scale integrating project). One or more proposal is expected to be funded. HEALTH : Characterisation of human genetic variation in Europe. FP7- HEALTH-2009-two-stageFunding scheme: Collaborative Project (Large scale integrating project). One or more proposal is expected to be funded. See also topic HEALTH : Comparative population genetic studies on multifactorial diseases. FP7-HEALTH-2009-single-stage.

25 Topics from first calls in Translating research for health Integrating biological data and processes: Systems biology -HEALTH : Systems biology approaches for basic biological processes relevant to health and disease. FP7-HEALTH-2009-two-stage. The projects should focus on modelling important biological processes at any appropriate levels of system complexity by generating and integrating quantitative data sets (e.g. transcriptomics, proteomics, metabolomics, structural biology, RNAi screening, physiology and/or patho-physiology). This large multidisciplinary effort should integrate the critical mass of excellence in Europe that is necessary for generating and validating the models using systems biology approaches. Funding scheme: Collaborative Project (Large-scale integrating project). One or more proposals are expected to be funded.

26 Collaborative research on the Health theme 2: Translating research for human health Integrating biological data and processes: large-scale data gathering, systems biology Research on the brain and related diseases, human development and ageing Translational research in major infectious diseases: to confront major threats to public health antimicrobial drug resistance, HIV/AIDS, malaria and TB, emerging epidemics, neglected infectious diseases Translational research in other major diseases: cancer, cardiovascular disease, diabetes and obesity, rare diseases, and other chronic diseases

27 Topics from first calls in Translating research for health Research on the Brain and related diseases: -HEALTH : Synaptopathies: genesis, mechanisms and therapy. FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Identifying genetic and environmental interactions in schizophrenia. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Optimising current therapeutic approaches to schizophrenia. FP7- HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Understanding the blood brain barrier (BBB) to improve drug delivery to the brain. FP7-HEALTH-2009-single-stage. The participation of SME is encouraged. Funding scheme: Collaborative Project (small or medium scale focused project). -HEALTH : Psycho-social factors of brain disorders. FP7-HEALTH-2009-singlestage. Funding scheme: Coordination and Support Action (Coordinating Action).

28 Collaborative research on the Health theme 2: Translating research for human health Integrating biological data and processes: large-scale data gathering, systems biology Research on the brain and related diseases, human development and ageing Translational research in major infectious diseases: to confront major threats to public health antimicrobial drug resistance, HIV/AIDS, malaria and TB, emerging epidemics, neglected infectious diseases Translational research in other major diseases: cancer, cardiovascular disease, diabetes and obesity, rare diseases, and other chronic diseases

29 Topics from first calls in Translating research for health Anti-microbial drug resistance: -HEALTH : Global collaborative research on the prevention of antibiotic resistance. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Impact of specific antibiotic therapies on the prevalence of resistant bacteria in the human host. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Clinical evaluation of point-of-care diagnostic tests for microbial detection and identification, antibiotic susceptibility determination and biomarkers. FP7- HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project).

30 Topics from first calls in Translating research for health HIV/AIDS, malaria and tuberculosis (1) -HEALTH : Integration of European efforts in research on malaria. FP7- HEALTH-2009-single-stage. Funding scheme: Network of Excellence. -HEALTH : Identification and pre-clinical testing of new vaccine candidates for tuberculosis. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Discovery and/or development of new and promising anti-hiv microbicides. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project) -HEALTH : Mucosal and tropical vaccines for poverty related diseases (HIV/AIDS, malaria and/or TB). FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large-scale integrated research project)). -HEALTH : Translational vaccine research for poverty-related diseases (HIV/AIDS, malaria and/or TB). FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : ERA-NET for stepping up European co-operation in HIV/AIDS research10. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination Action and support (Coordinating Action).

31 Topics from first calls in Translating research for health Emerging epidemics -HEALTH : Efficacy and effectiveness of personal protection equipment and other measures against influenza transmission. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project).

32 Collaborative research on the Health theme 2: Translating research for human health Integrating biological data and processes: large-scale data gathering, systems biology Research on the brain and related diseases, human development and ageing Translational research in major infectious diseases: to confront major threats to public health antimicrobial drug resistance, HIV/AIDS, malaria and TB, emerging epidemics, neglected infectious diseases Translational research in other major diseases: cancer, cardiovascular disease, diabetes and obesity, rare diseases, and other chronic diseases

33 Topics from first calls in Translating research for health Cancer No topics

34 Topics from first calls in Translating research for health Cardiovascular disease -HEALTH : Improved or new therapeutic approaches for the treatment of heart failure. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Cardiac arrhythmias: from genes to improved management of patients. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Translation of basic knowledge on inherited cardiomyopathies into clinical practice. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). See also topic HEALTH : Mechanisms of diabetic and weight-related comorbidity in heart failure. FP7-HEALTH-2009-single-stage.

35 Topics from first calls in Translating research for health Diabetes and obesity (1) -HEALTH : Novel therapeutical approach to pregnancyinduced diabetes. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project. -HEALTH : Novel immunotherapies for type 1 diabetes. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Large scale integrating project). -HEALTH : Molecular pathways in food intake at CNS-livergut regulation level. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project).

36 Topics from first calls in Translating research for health Rare Diseases -HEALTH : Rare neurological diseases. FP7- HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium scale focused project). -HEALTH : Preclinical development of substances with a clear potential as orphan drugs. FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project).

37 Topics from first calls in Translating research for health Other chronic diseases -HEALTH : Prevention and treatment of nonalcoholic fatty liver disease (NAFLD). FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Cellular and molecular mechanisms of development of chronic kidney disease (CKD). FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Large scale integrating project).

38 Collaborative research on the Health theme 3. OPTIMISING THE DELIVERY OF HEALTHCARE TO EUROPEAN CITIZENS TRANSLATING THE RESULTS OF CLINICAL RESEARCH OUTCOME INTO CLINICAL PRACTICE INCLUDING BETTER USE OF MEDICINES, AND APPROPRIATE USE OF BEHAVIOURAL AND ORGANISATIONAL INTERVENTIONS AND NEW HEALTH THERAPIES AND TECHNOLOGIES QUALITY, EFFICIENCY AND SOLIDARITY OF HEALTHCARE SYSTEMS INCLUDING TRANSITIONAL HEALTH SYSTEMS ENHANCED HEALTH PROMOTION AND DISEASE PREVENTION

39 TRANSLATING THE RESULTS OF CLINICAL RESEARCH OUTCOME INTO CLINICAL PRACTICE INCLUDING BETTER USE OF MEDICINES, AND APPROPRIATE USE OF BEHAVIOURAL AND ORGANISATIONAL INTERVENTIONS AND NEW HEALTH THERAPIES AND TECHNOLOGIES -HEALTH : Patient Safety: Effective implementation of prevention strategies for healthcare associated infections. FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Small or mediumscale focused research project). -HEALTH : Improve quality and safety of hospital care. FP7-HEALTH-2009-single-stage. Study the relationship of organisational quality management and culture, professionals' involvement, and patient empowerment Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Complementary and Alternative Medicine. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination and Support Action (Coordinating Action). -HEALTH : Improved treatment of chronic diseases in developing countries. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). See also topic HEALTH : Strategies and interventions for improving reproductive health (SICA).

40 QUALITY, EFFICIENCY AND SOLIDARITY OF HEALTHCARE SYSTEMS INCLUDING TRANSITIONAL HEALTH SYSTEMS -HEALTH : Organisation of dementia care. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Healthcare outcomes and cost-benefits. FP7-HEALTH single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Primary care quality linkage to costs. FP7-HEALTH-2009-singlestage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Impact of cross border collaboration on health services. FP7- HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or mediumscale focused research project). -HEALTH : Research access to comparable healthcare data. FP7-HEALTH single-stage. Funding scheme: Coordination and Support action (Coordinating action). -HEALTH : Scoping study to address the methodological challenges of quantifying the socio-economic burden of brain diseases in the enlarged European Union compared to other major diseases. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination and Support Action (Supporting Action). See also topics HEALTH : Access to medicines (SICA) and HEALTH : Integration of Disease Surveillance and Health Systems Response (SICA).

41 ENHANCED HEALTH PROMOTION AND DISEASE PREVENTION -HEALTH : Child and adolescent mental health. FP7- HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Environmental prevention of substance abuse by adolescents. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Ageing cohorts. FP7-HEALTH-2009-singlestage. Funding scheme: Collaborative Project (Large-scale focused research project). -HEALTH : Birth/Mother - Child Cohorts co-ordination. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination and Support Action (Coordinating Action). -HEALTH : European child health research platform. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination and Support Action (Coordinating Action).

42 4. OTHER ACTIONS ACROSS THE HEALTH THEME 4.1. COORDINATION AND SUPPORT ACTIONS ACROSS THE THEME -HEALTH : Monitoring tool and technology transfer analysis for health grants during FP7. FP7-HEALTH-2009-singlestageFunding scheme: Coordination and Support Action (Supporting Action). -HEALTH : Dissemination of results from research in Life Sciences and Biotechnology for Health to the general public and/or information multipliers. FP7-HEALTH-2009-single-stage. Funding scheme: Coordination and Support Action (Coordinating Action or Supporting Action). One or more proposal is expected to be funded. -HEALTH : Targeting publication bias. FP7-HEALTH single-stage. Funding scheme: Coordination and Support Action (Supporting Action).

43 4. OTHER ACTIONS ACROSS THE HEALTH THEME 4.2. RESPONDING TO EU POLICY NEEDS -HEALTH : Adapting off-patent medicines to the specific needs of paediatric populations. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project). -HEALTH : Study of the Arrhythmogenic potential of different classes of medicines. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative projects (Small or medium-scale focused research project). -HEALTH : Human Papillomavirus Vaccination (HPV) and cervical cancer screening programmes: estimate of impact of different policy options by way of disease modelling and health economics. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (Small or medium-scale focused research project).

44 4. OTHER ACTIONS ACROSS THE HEALTH THEME 4.3. SPECIFIC INTERNATIONAL COOPERATION ACTIONS (SICA) Neglected infectious diseases. -HEALTH : Discovery and development of new vaccines or drugs for helminth infections. FP7-HEALTH single-stage. Target Regions: All International Cooperation Partner Countries, see annex I of the work programme. Funding scheme: Collaborative Project (SICA) (Small or medium-scale focused research project). -HEALTH : Identification and development of vaccine candidates for neglected bacterial infections. FP7-HEALTH single-stage. Target Regions: All International Cooperation Partner Countries, see annex I of the work programme. Funding scheme: Collaborative Project (SICA) (Small or medium-scale focused research project). -HEALTH : Human Immune Responses to co-infections of Poverty-Related (HIV, malaria, TB) and Neglected Infectious Diseases. FP7-HEALTH-2009-single-stage. Target Regions: ACP Countries see annex I of the work programme. Funding scheme: Collaborative Project (SICA) (Large scale integrating project).

45 4. OTHER ACTIONS ACROSS THE HEALTH THEME 4.3. SPECIFIC INTERNATIONAL COOPERATION ACTIONS (SICA) International Public Health and Health Systems -HEALTH : Strategies and interventions for improving reproductive health. FP7-HEALTH-2009-single-stage. Target Regions: All International Cooperation Partner Countries, see annex I of the work programme. Funding scheme: Collaborative Project (SICA) (Small or medium-scale focused research project). -HEALTH : Access to medicines. FP7-HEALTH-2009-single-stage. Target Regions: International Collaboration Partner Countries (ICPC), see Annex I of the work programme. Funding scheme: Collaborative Project (SICA) (Small or medium-scale focused research project). -HEALTH : Integration of Disease Surveillance and Health Systems Response. FP7-HEALTH-2009-single-stage. Target Region: ACP, Asia. Funding scheme: Collaborative Project (SICA) (Small or medium-scale focused research project) Coordinated topics with Russia -HEALTH : Comparative population genetic studies on multifactorial diseases. FP7-HEALTH-2009-single-stage. Genome-wide association studies have been shown to be a powerful approach to study genetics of common diseases. The project should focus on comparative population genomics studies on several multifactorial diseases in populations in the EU and Russia. Funding scheme: Collaborative Project (SICA) (Small or medium-scale focused research project). Only one proposal will be funded. -HEALTH : Mechanisms of diabetic and weight-related co-morbidity in heart failure. FP7-HEALTH-2009-single-stage. Funding scheme: Collaborative Project (SICA) (Small or medium-scale focused research project). Only one proposal will be funded.

46 Directorate F - Health F1 Horizontal aspects and coordination Head of unit: Stéphane Hogan F2 Medical and public health research Head of unit: Manuel Hallen F3 Infectious diseases Acting Head of unit: Bernard Mulligan F4 Genomics and systems biology Acting Head of unit: Jacques Remacle F5 Health biotechnology Head of Unit: Arnd Hoeveler F6 Unit of administration and finance Acting Head of unit: Georgios Zisimatos

47 Contacts in the Health Directorate Acting Director Dr. Manuel Hallen Medical and Public Health Research unit Dr. Manuel Hallen Cancer Dr. Maria Vidal Public Health sector Dr. Kevin McCarthy Infectious Diseases unit Dr. Bernard Mulligan Emerging Infectious diseases sector Dr. Anna Lönnroth Genomics and Systems Biology unit Dr. Jacques Remacle Health Biotechnology unit Dr. Arnd Hoeveler Coordination unit Stéphane Hogan

48 Contacts & Information IMI contact: Dr. Irene Norstedt Tel irene.norstedt@ec.europa.eu Innovative Medicines Initiative (IMI): SME contact: Dr. Ludovica Serafini Tel ludovica.serafini@ec.europa.eu International Cooperation contact: Dr. Indridi Benediktsson Tel indridi.benediktsson@ec.europa.eu Framework Programme 7:

49 Information EU research: Seventh Framework Programme: Information on research programmes and projects: RTD info magazine: Information requests:

50 Funding schemes Collaborative projects Networks of Excellence Coordination and support actions Individual projects Support for training and career development of researchers Research for the benefit of specific groups (in particular SMEs)

51 Participation, minimum conditions 3 independent legal entities from three different Member States or Associated countries Additional conditions may be laid down in the work programme or specific programme (ex. number of participants, place of establishment, type of participant) Natural persons

52 Participation, minimum conditions Frontier research actions (ERC): at least 1 legal entity established in a Member State or in an Associated country Coordination and support actions and actions in favour of training and career development of researchers at least 1 legal entity (except coordination actions) Legal entities established in third countries and international organisations may participate after minimum conditions have been met

53 General principles, forms of grants Forms of grants Reimbursement of eligible costs Flat rate financing, including scale of unit cost Lump sum financing Combination possible No cost reporting models Participants charge direct and indirect costs Flat rate always an option for indirect costs Co-financing, no profit Grant agreement will specify forms of grants

54 Eligible costs Average personnel costs may be used if consistent with the above principles and practices and do not differ significantly from actual costs Audit certificates will be requested, but rationalised: when cumulative amount of payments to participant = or more - project duration of 2 years or less, only 1 audit certificate at the end if = or more

55 Indirect costs, OH Real indirect costs Simplified method if in accordance with usual accounting and management principles and practices - principles in model grant agreeement Flat rate of total direct eligible costs (excl. subcontracting or third parties costs), 20%

56 Indirect costs, OH, cont. Non-profit public bodies, secondary and higher education establishments, research organisations and SMEs, unable to identify with certainty real indirect costs - Flat rate equal to 60% of total direct eligible costs in calls for proposals closing before 1 January appropriate level of flat rate which should be an approximation of real indirect costs, but not lower than 40% in calls for proposals closing after 31 December 2009 CSA, 7% All flat rates shall be set out in the model grant agreement

57 Upper funding limits Research and technological development activities 50% of total eligible costs except for: Non-profit public bodies 75% Secondary and higher education establishments 75% Research organisations (non-profit) 75% SMEs 75% Demonstration activities 50% of total eligible costs Some security related research and technological development activities 75% Frontier research actions 100%

58 Upper funding limits, cont. Other activities, incl. management 100% of total eligible costs Coordination and support actions 100% of total eligible costs Training and career development of researchers actions 100% of total eligible costs Receipts to be taken into consideration

59 Risk avoidance mechanism Commission shall establish and operate a participant guarantee fund - max. 5% of Commission contribution - to be returned at the end of the action - interest generated by the fund to cover sums due to the Community - if not sufficient, Commission may deduct from amount to be returned to a participant max. 1% of Community contribution to it.

60 Risk avoidance mechanism, cont. Shall not apply to: -public bodies -legal entities guaranteed by a Member State or an Associated country -higher and secondary education establishments

61 Risk avoidance mechanism, cont. Verification ex ante only of: - coordinators, - those applying for Community contribution in excess of , (except public bodies, legal entities guaranteed by a MS or an Ac, higher and secondary education establishments) - others only in exceptional circumstances when justified grounds to doubt financial capacity of these participants No additional guarantees or security may be requested from participants or be imposed on them

62 Intellectual Property Background (Pre-existing existing know-how in FP6) = Information held by participants prior to their accession to the grant agreement (no longer includes sideground) which is needed to carry out the project or for using the results of the project Foreground (Knowledge in FP6) = Results, incl. information, generated by the indirect action concerned

63 Intellectual Property, cont. Ownership: participant owns the foreground it generates Joint ownership: agreement required on allocation and terms (where no specific agreement yet, default joint ownership applies): Each joint owner can grant non-exclusive licenses to third parties with no right to sub-licence, subject to prior notice and fair and reasonable compensation to the other joint owner(s) Guidance by the Commission on request

64 Intellectual Property, cont. Protection, use and dissemination (including publication) Owner shall protect foreground capable of industrial or commercial application Owner may transfer foreground if it does not protect it Foreground shall be used and disseminated Notice of dissemination (incl. publication) shall be given to other participants concerned (if no protection, also to the Commission) Publications and patent applications shall indicate the Community financial assistance

65 Intellectual Property, cont. Access rights Participants may define the background needed and may, where appropriate, exclude specific background Up to one year after end of action, but other period may be agreed by participants Exclusive licenses to background and foreground possible if other participants waive their access rights in writing

66 Access rights Access rights to background Access rights to foreground resulting from the project For carrying out the project For use (exploitation + further research) Yes, if a participant needs them for carrying out its own work under the project Royalty-free unless otherwise agreed before acceding to the grant agreement Royalty-free Yes, if a participant/affiliate needs them for using its own foreground Either fair and reasonable conditions or royalty freeto be agreed

67 Supporting documents, guidelines Model grant agreement Commission will adopt and publish rules on the procedures for proposal submission, evaluation, selection of proposals and award of grants, as well as redress procedures for participants Commission will adopt and publish rules to ensure consistent verification of the legal status and financial capacity of participants Guidelines on consortium agreements Financial guidelines IPR guidelines Etc.